09:48 AM EST, 01/13/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Monday that it expects fiscal 2024 adjusted EPS and revenue to be at or above the guidance ranges provided on Nov. 8.

ANI also said it expects fiscal 2025 revenue in the range of $739 million to $759 million. Analysts surveyed by FactSet expect $720.3 million.

Shares of the company were down 2% in recent Monday trading.

Price: 53.92, Change: -1.12, Percent Change: -2.03